Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 5/20 | 0.35 |
| ▸ | BCAT2 | O15382 | 3/20 | 0.35 |
| ▸ | PPOX | P50336 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 7/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27044937 | 1.00 | BCAT1 (0.35) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL3850293 | 0.89 | BCAT1 (0.39) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL25291362 | 0.88 | PPOX (0.37) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL30841843 | 0.88 | PPOX (0.37) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL25302151 | 0.88 | BCAT1 (0.39) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL25424544 | 0.87 | L3MBTL1 (0.35) | BCAT1BCAT2MEN1LMNAKMT2A | |
| SCHEMBL13843249 | 0.86 | PPOX (0.46) | BCAT1BCAT2PPOXMEN1LMNA | |
| SCHEMBL3245244 | 0.85 | BCAT1 (0.39) | BCAT1BCAT2MEN1LMNAKMT2A | |
| SCHEMBL29452779 | 0.85 | BCAT1 (0.39) | BCAT1BCAT2MEN1LMNAKMT2A | |
| SCHEMBL27044947 | 0.85 | BCAT1 (0.39) | BCAT1BCAT2PPOXMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | PFAS, DDT, NOTUM | BCAT1 352/4885BCAT2 411/4885PPOX 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.